Evidence map›Paper›PMID 21612237›Full record

ArticleJournal of the American Chemical Society2011

Nucleobase and ribose modifications control immunostimulation by a microRNA-122-mimetic RNA.

Hayden Peacock, Raymond V Fucini, Prasanna Jayalath, José M Ibarra-Soza, Henry J Haringsma, W Michael Flanagan, Aarron Willingham, Peter A Beal

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  14. Injured liver-released miRNA-122 elicits acute pulmonary inflammation via activating alveolar macrophage TLR7 signaling pathway.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The code of non-coding RNAs in lung fibrosis.Cellular and molecular life sciences : CMLS · 2015
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hayden PeacockDepartment of Chemistry, University of California-Davis, One Shields Avenue, Davis, California 95616, USA.
Raymond V Fucini
Prasanna Jayalath
José M Ibarra-Soza
Henry J Haringsma
W Michael Flanagan
Aarron Willingham
Peter A Beal
University of California, Davis · US

Funding

Nucleobase analogs for next generation siRNAsR01GM080784 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BEAL, PETER A. · 2007 to 2020
$3.5M
NIGMS NIH HHS R01 GM080784
6 · The paper itself

Abstract

Immune stimulation is a significant hurdle in the development of effective and safe RNA interference therapeutics. Here, we address this problem in the context of a mimic of microRNA-122 by employing novel nucleobase and known 2'-ribose modifications. The nucleobase modifications are analogues of adenosine and guanosine that contain cyclopentyl and propyl minor-groove projections. Via a site-by-site chemical modification analysis, we identify several immunostimulatory 'hot spots' within the miRNA guide strand at which single base modifications significantly reduce immune stimulation. A duplex containing one base modification on each strand proved to be most effective in preventing immune stimulation.

Indexed as

AnimalsBase SequenceBiomimetic MaterialsCell Line, TumorCytokinesGene Knockdown TechniquesImmune SystemMiceMicroRNAsRiboseRNA, Double-StrandedCytokinesMicroRNAsMirn122 microRNA, mouseRiboseRNA, Double-Stranded

Identifiers

PMID21612237
PMCPMC3116021
OpenAlexW2073741546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.